KURA

Kura Oncology (KURA)

Kura Oncology Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KURA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/02/06	06 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KURA	Kura Oncology Inc
2025/02/06	06 : 01	GlobeNewswire Inc.	Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs	NASDAQ:KURA	Kura Oncology Inc
2025/01/29	10 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/29	10 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/29	10 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/29	10 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/29	10 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/29	10 : 37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/29	10 : 37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/29	10 : 37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/29	10 : 37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/29	10 : 37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/29	10 : 36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/15	06 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KURA	Kura Oncology Inc
2025/01/09	09 : 42	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:KURA	Kura Oncology Inc
2025/01/08	07 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/08	07 : 42	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/08	07 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/08	07 : 25	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/07	06 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KURA	Kura Oncology Inc
2025/01/07	06 : 30	GlobeNewswire Inc.	Kura Oncology Announces Senior Executive Promotions	NASDAQ:KURA	Kura Oncology Inc
2025/01/07	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/07	06 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/07	06 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/07	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2025/01/07	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KURA	Kura Oncology Inc
2024/12/21	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KURA	Kura Oncology Inc
2024/12/09	21 : 00	GlobeNewswire Inc.	Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting	NASDAQ:KURA	Kura Oncology Inc
2024/12/02	21 : 30	GlobeNewswire Inc.	Kura Oncology to Host Virtual Investor Event on December 9, 2024	NASDAQ:KURA	Kura Oncology Inc
2024/11/25	21 : 30	GlobeNewswire Inc.	Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit	NASDAQ:KURA	Kura Oncology Inc